Clik here to view.
Clik here to view.
Minomic Announces Clinical Study Update for MILGa in Prostate, Bladder and...
SYDNEY Minomic International Ltd (Minomic) is an immuno-oncology company specializing in therapeutics and diagnostics for solid tumors, including prostate, bladder and pancreas. The Company today...
View ArticleClik here to view.
オクタファルマ、発展途上国の血友病A患者が利用できるようNuwiq®をWFH人道支援プログラムに寄付
スイス・ラッヘン （ビジネスワイヤ） — オクタファルマは、当社の第4世代ヒト細胞株由来組み換え型第VIII因子製剤（Nuwiq®）450万ユニットを世界血友病連盟（WFH）の人道支援プログラムに慈善活動として寄付したとことを発表します。...
View ArticleClik here to view.
Kite Pharma Establishes a Strategic Partnership With Daiichi Sankyo to...
SANTA MONICA, Calif. Kite Pharma (Nasdaq:KITE) announced today that it has entered into a strategic partnership with Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) for axicabtagene ciloleucel (approved...
View ArticleClik here to view.
PerkinElmer to Acquire Tulip Diagnostics Private Limited in India
WALTHAM, Mass. PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it has entered into a definitive agreement to acquire Tulip...
View ArticleClik here to view.
PerkinElmer to Acquire Tulip Diagnostics Private Limited in India
GOA, India PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that it has entered into a definitive agreement to acquire Tulip Diagnostics Private Ltd....
View ArticleClik here to view.
武田与PvP Biologics宣布开发乳糜泻治疗新药的协议
日本大阪和圣迭戈和西雅图 (美国商业资讯) — 武田药品工业株式会社（“武田”）(TOKYO:4502)与PvP Biologics, Inc. (“PvP”)今天宣布签署一份开发新型酶KumaMax的全球性协议，该酶旨在于胃中降解麸质中引起免疫反应的部分，从而避免意外摄入麸质所致的疼痛症状和对小肠造成的损伤。 Smart News...
View ArticleClik here to view.
高德美医学美容“谐美计划”经市场调研证明取得了卓越的成功！
瑞士洛桑 (美国商业资讯) – 通过市场调研证实，高德美针对医学美容方向医疗专业人士(HCPs)的谐美计划大幅提高了求美者满意度。在应用谐美后，获得了更多的忠实求美者，全面部治疗率也得到提高。该调研结果显示了谐美是如何同时提升了医学美容实践中的治疗标准和价值的。...
View ArticleClik here to view.
Kite Pharma and Fosun Pharma Establish Joint Venture in China to Develop and...
SANTA MONICA, Calif. & SHANGHAI Kite Pharma (Nasdaq:KITE) and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma) (600196.SH,02196.HK), today announced a joint venture, Fosun Pharma...
View ArticleClik here to view.
LFB S.A.、血液凝固第VIIa因子組み換え製剤（活性型エプタコグベータ）に関し提出済みの生物学的製剤承認申請を米食品医薬品局（FDA）が受理したと本日発表
仏レジュリス （ビジネスワイヤ） — LFB...
View ArticleClik here to view.
Pharmaron Acquires Xceleron Inc.
BEIJING Pharmaron, a fully integrated contract research organization offering R&D services for the life science industry, today announced the acquisition of Xceleron Inc. Xceleron is a Maryland,...
View ArticleClik here to view.
POC Medical Systems™ Raises $21 Million in Series A Funding to Advance Rapid,...
LIVERMORE, Calif. POC Medical Systems™ Inc. announced today that it raised $ 21 million in Series A funding for clinical beta testing and initial commercialization of a rapid, portable breast cancer...
View ArticleClik here to view.
Seqirus and Zambon Enter into a Partnership for Parkinson’s Disease Product...
MILAN Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system (CNS)...
View ArticleClik here to view.
Professor Tadamitsu Kishimoto of Osaka University Wins Medicine Category of...
OSAKA, Japan Emeritus Professor Tadamitsu Kishimoto of Immunology Frontier Research Center at Osaka University in Japan has won the Medicine category of the King Faisal International Prize (KFIP)...
View ArticleClik here to view.
Maverick Therapeutics and Takeda Announce Five-year Collaboration to Advance...
BRISBANE, Calif. & CAMBRIDGE, Mass. & OSAKA, Japan Maverick Therapeutics Inc., an MPM Capital portfolio company, and Takeda Pharmaceutical Company Limited (TSE:4502) announced today that...
View ArticleClik here to view.
GI Dynamics, Inc. Provides 2017 Business Outlook and 2016 Review
BOSTON & SYDNEY GI Dynamics, Inc., (ASX:GID), a medical device company that has commercialized EndoBarrier® in Europe for patients with type 2 diabetes and obesity, today released a 2017...
View ArticleClik here to view.
Orthocell Announces Collaboration with Johnson & Johnson Innovation
PERTH, Australia Regenerative medicine company Orthocell Limited has today announced a research collaboration agreement with DePuy Synthes Products, Inc., part of the Johnson & Johnson Family of...
View ArticleClik here to view.
大阪大学の岸本忠三教授が2017年度キング・ファイサル国際賞の医学部門賞を受賞
大阪 （ビジネスワイヤ） — 大阪大学免疫学フロンティア研究センターの岸本忠三名誉教授が、自己免疫疾患に対する斬新な生物学的治療の開発で重大な役割を果たした功績により、2017年度キング・ファイサル国際賞（KFIP）の医学部門賞を受賞しました。 このSmart News Release（スマート・ニュース・リリース）にはマルチメディアのコンテンツが含まれています。リリース全文はこちらから：...
View ArticleClik here to view.
Bioventus选择MEDSERVICE作为DUROLANE®在俄罗斯的经销商
荷兰霍夫多普 — (美国商业资讯) — 骨科生物制剂解决方案领导者Bioventus宣布，该公司已选择MEDSERVICE作为DUROLANE®在俄罗斯的经销商。DUROLANE为单次注射关节液，基于一种称为NASHA®的天然、安全且经过验证的技术加工，产生稳态透明质酸(HA)。透明质酸是一种天然形成的分子，在正常关节中提供润滑和缓冲作用。 Smart News...
View ArticleClik here to view.